Skip to main content
Veterinary Medicines

Coxaclear 50 mg/ml oral suspension for pigs, cattle and sheep

Authorised
  • Toltrazuril

Product identification

Medicine name:
Coxaclear 50 mg/ml oral suspension for pigs, cattle and sheep
Toltranil
Active substance:
  • Toltrazuril
Target species:
  • Cattle
  • Sheep
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Toltrazuril
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        63
        day
    • Sheep
      • Meat and offal
        42
        day
    • Pig
      • Meat and offal
        77
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51AJ01
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • Bottle (HDPE), closure (HDPE), sealing liner (LDPE): 250 ml of oral suspension, in a box.
  • Bottle (HDPE), closure (HDPE), sealing liner (LDPE): 1000 ml of oral suspension.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
  • Virbac
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402069.00.00
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0234/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."